Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase
- PMID: 2392503
- DOI: 10.1007/BF02245738
Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase
Abstract
The antidepressant rolipram interacts in vitro with a binding site in brain tissue labeled by 3H-rolipram. A 3H-rolipram binding assay was employed in vivo to compare the affinity of rolipram-related compounds and reference phosphodiesterase (PDE) inhibitors with their potency in behavioural measures for potential antidepressant property. In two species, mice and rats, the potency of a number of compounds to antagonise reserpine-induced hypothermia (mice) and to induce head twitches (rats) was determined, as well as their potency to displace 3H-rolipram from forebrain binding sites in vivo. The treatment schedules for the two series of experiments were identical. Significant correlations between pharmacological effects and displacement of 3H-rolipram binding in vivo were observed in both species. Since the reference PDE inhibitors closely fit into the binding-pharmacological activity relationship, the PDE inhibitory properties of the substances involved are discussed.
Similar articles
-
Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.J Neural Transm. 1983;56(2-3):139-52. doi: 10.1007/BF01243273. J Neural Transm. 1983. PMID: 6190991
-
Antidepressant properties of some phosphodiesterase inhibitors.Pol J Pharmacol Pharm. 1983 May-Jun;35(3):233-40. Pol J Pharmacol Pharm. 1983. PMID: 6194518
-
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.Neuropharmacology. 1983 Mar;22(3):267-72. doi: 10.1016/0028-3908(83)90239-3. Neuropharmacology. 1983. PMID: 6302550
-
Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.Psychopharmacology (Berl). 1982;77(4):309-16. doi: 10.1007/BF00432761. Psychopharmacology (Berl). 1982. PMID: 6182575
-
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.J Med Chem. 1996 Jan 5;39(1):120-5. doi: 10.1021/jm9505066. J Med Chem. 1996. PMID: 8568798
Cited by
-
Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.Biochem J. 1997 Dec 1;328 ( Pt 2)(Pt 2):549-58. doi: 10.1042/bj3280549. Biochem J. 1997. PMID: 9371714 Free PMC article.
-
Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.Biochem J. 1996 Sep 1;318 ( Pt 2)(Pt 2):425-36. doi: 10.1042/bj3180425. Biochem J. 1996. PMID: 8809029 Free PMC article.
-
Insight into Inhibitory Mechanism of PDE4D by Dietary Polyphenols Using Molecular Dynamics Simulations and Free Energy Calculations.Biomolecules. 2021 Mar 23;11(3):479. doi: 10.3390/biom11030479. Biomolecules. 2021. PMID: 33806914 Free PMC article.
-
Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.Biochem J. 1993 Apr 15;291 ( Pt 2)(Pt 2):389-95. doi: 10.1042/bj2910389. Biochem J. 1993. PMID: 8387267 Free PMC article.
-
The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens.Psychopharmacology (Berl). 2009 Oct;206(2):177-85. doi: 10.1007/s00213-009-1594-4. Epub 2009 Jul 9. Psychopharmacology (Berl). 2009. PMID: 19588125
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical